Antigen binding molecules specific for an anti-CD19 scFV
US12202909B2 · kind B2 · utility
0Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2022 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Nov 26, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.